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Objectives: The distribution and function of lymphatic vessels in normal and diseased human knees are
understood incompletely. This study aimed to investigate whether lymphatic density is associated with
clinical, histological or radiographic parameters in osteoarthritis (OA).
Methods: Sections of synovium from 60 knees from patients with OA were compared with 60 post
mortem control knees (from 37 individuals). Lymphatic vessels were identiﬁed using immunohisto-
chemistry for podoplanin, and quantiﬁed as lymphatic vessel density (LVD) and lymphatic endothelial
cell (LEC) fractional area. Effusion status was determined by clinical examination, radiographs were
scored for OA changes, and inﬂammation grading used haematoxylin and eosin stained sections of
synovium.
Results: Lymphatic vessels were present in synovia from both disease groups, but were not identiﬁed in
subchondral bone. Synovial lymphatic densities were independent of radiological severity and age.
Synovia from patients with OA displayed lower LVD (z¼3.4, P¼ 0.001) and lower LEC fractional areas
(z¼4.5, P< 0.0005) than non-arthritic controls. In patients with OA, low LVD was associated with
clinically detectable effusion (z¼2.2, P¼ 0.027), but not with histological evidence of synovitis. The
negative associations between lymphatics and OA/effusion appeared to be independent of other
measured confounders.
Conclusion: Lymphatic vessels are present in lower densities in OA synovia. Abnormalities of synovial
ﬂuid drainage may confound the value of effusion as a clinical sign of synovitis in OA.
 2012 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Synovial pathology is increasingly recognised as a potential
target for treatment in osteoarthritis (OA). Synovial inﬂammation
and effusion may contribute to symptoms and progressive joint
damage in OA. Lymphatic vessel abnormalities may contribute to
inﬂammation and tissue ﬂuid accumulation, but have previously
attracted little attention in the osteoarthritic synovium.
Lymphatics are responsible for tissue ﬂuid clearance and the
transit of macromolecules to lymph nodes, where they may stim-
ulate speciﬁc immune responses. Lymphatics are present in
human1e5 and rodent6e8 synovium, accompanying arterioles and
venules. Functionality of the articular lymphatic system has been
demonstrated as clearance of macromolecules from synovial cavity.A. Walsh, Arthritis Research
ity of Nottingham, Clinical
B, UK. Tel: 44-115-823-1751;
.A. Walsh).
s Research Society International. Pinto draining lymphatics9,10. However, changes that may occur in
lymphatic vessels during arthritis remain incompletely understood.
Lymphangiogenesis, the growth of new lymphatic vessels, is
regulated by factors such as vascular endothelial growth factors
(VEGF)-C and D through the receptor VEGFR-311. Lymphangio-
genesis is increased during wound healing, inﬂammation and
neoplasia. Inﬂammation can stimulate lymphangiogenesis through
the upregulation of VEGF-C, for example in synovitis7,12, and
increased abundance of Lymphatic Vessel Endothelium receptor-1
(LYVE-1) immunoreactive vessels have been reported in the
superﬁcial regions of inﬂamed synovia2.
In contrast to the expected increase in lymphangiogenesis in
inﬂamed synovium, OA has also been associated with deﬁcient ﬂuid
clearance. Presence or absence of synovial effusion, although often
used clinically as a signof inﬂammation, is a poorpredictorof response
to anti-inﬂammatory treatments such as intra-articular corticoste-
roids in OA13. Normally, trans-synovial ﬂow is well maintained to
preserve ﬂuid homeostasis and prevent joint swelling. In joints with
chronic effusions, this ﬂow may exceed capacity for lymphatic
drainage10,14. Furthermore, clearance of macromolecules is low from
OA synovial cavities suggesting dysregulated lymphatic function10.ublished by Elsevier Ltd. All rights reserved.
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has not been explored in detail. Normal bone marrow is devoid of
lymphatics, with ﬂuid clearance being through venous sinusoids
within the marrow cavities. However, subchondral bone marrow
may be replaced by ﬁbrovascular tissue in OA15 and, with the loss of
integrity of the osteochondral junction, subchondral bone may also
provide a route of ﬂuid clearance from the synovial cavity16.
Interpretation of previous studies of lymphatic vessels in joint
tissues is hampered by small case numbers, control tissues with
limited clinical characterisation and qualitative methodologies.
Antigenic markers that are normally speciﬁc for lymphatic endo-
thelium, may cross react with blood vessel endothelium in
inﬂamed tissues12,17 and loss of speciﬁcity of markers may have
contributed to the apparent absence of lymphatics in some studies
of joint tissues1. Lymphatics comprise <5% of total (lymphatic and
blood) vessels in human synovium, and, given the established
increase in synovial angiogenesis during inﬂammation18,19, any
cross reactivity of reagentswith blood vessels may artiﬁcially create
an impression of increased lymphatic density.
Podoplanin is a mucin-type transmembrane glycoprotein that is
a commonly used lymphatic marker as it is expressed by lymphatic
endothelial cells (LECs), andpossibly somemacrophages20, but not by
blood vascular endothelium21e23. It co-localiseswith VEGFR-3, and is
expressed on Pathologische Anatomie Leiden-Endothelium (PAL-E)
negative vessels, reinforcing its speciﬁcity for lymphatic vessels24.
A fuller characterisation of lymphatic distribution in OA is
important in establishing any potential roles for lymphatics in
regulating inﬂammation and clearing tissue ﬂuid. This study aimed
to investigate the distribution of lymphatics in normal and arthritic
human knees, to quantify any differences in lymphatic densities
between disease groups, and to explore any possible relationships
betweenvariations in lymphatic density, synovitis and joint effusion
status. We hypothesise that a decrease in the number of lymphatic
vessels in theosteoarthritic synovium leads todecreaseddrainage of
synovial ﬂuid from the joint, thereby contributing to joint effusion.
Materials and methods
Sample collection and processing
The studywas approved by the National Research Ethics Service,
reference numbers 05/Q2403/24, 05/Q2403/61, NNHA/420, NNHA/
405, NNHA/473 and NN/544. All those who had donated tissue had
provided informed consent as per the Declaration of Helsinki.
Archival material in the Division of Academic Rheumatologywas
collected at Sherwood Forest Hospitals NHS Foundation Trust, Sut-
ton in Ashﬁeld, UK. Each OA sample was taken during a total knee
replacement arthroplasty from patients who satisﬁed American
College of Rheumatology criteria for the diagnosis of kneeOA25. Post
mortem tissues were processed identically to surgical samples after
harvesting by an experienced technician. Synovium from adjacent
to the medial tibial plateau, and mid-coronal slices of medial tibial
plateaux were ﬁxed in formalin. These sites were selected based on
the higher prevalence and severity of OA in themedial tibial plateau,
and the a priori hypothesis that synovium ismore likely to inﬂuence
and be inﬂuenced by adjacent bone and cartilage than is that at
more distant locations. Medial tibial plateaux were immersed in
ethylenediaminetetraacetic acid (EDTA) at room temperature until
decalciﬁcation was conﬁrmed by radiography. Samples were wax-
embedded and 5 mm sections used for histological analysis.
Sample selection
An initial pilot study of OA (n¼ 15), rheumatoid arthritis (RA)
(n¼ 16) and post-mortem (n¼ 15) tissues suggested that lymphaticdensities might be lower than normal in OA synovia. A power
calculation26 based on these data indicated a required sample size of
52 synovia per group to give 80% power of detecting the observed
difference between OA and PM as signiﬁcant at the 5% level.
Samples were purposively selected for this study in order to
minimise the likelihood of joint disease in post mortem controls,
and to permit attribution of ﬁndings to OA rather than demo-
graphic status, given the strong association of OA prevalence with
age and gender. Sixty post mortem knees were selected from 37
cases. Post mortem knees were excluded from patients who were
known to have OA or other arthropathy, if Heberden’s nodes were
identiﬁed by clinical examination, or if either osteophytes (OST) or
grade III or IV chondropathy was apparent on macroscopic exam-
ination of tibial plateaux and femoral condyles27. Sixty OA cases
were selected, one OA case agematched within 6 years to each post
mortem knee. Where more than one age-matched sample was
available in the archive, OA cases were selected to be matched by
gender, and by age closest to the PM case.
Synovia from all 120 knees (60 OA and 60 post mortem knees)
were used for analysis of podoplanin immunoreactivity, as per our
original protocol. Analyses were repeated using only one knee,
randomly selected from each of the 37 post mortem cases in order
to ensure that unknown intra-person factors did not invalidate
statistical presumptions about independence of observations.
A subgroup of 20 cases, comprising 10 OA and 10 post mortem
cases, was selected for further evaluation of podoplanin immuno-
reactivity in subchondral bone. A subgroup of nine cases,
comprising six OA and three post mortem cases, was selected for
evaluation of LYVE-1 and CD34 immunoreactivities, and possible
associations with podoplanin-immunoreactivity determined by
staining of consecutive tissue sections.
Histochemistry
Haematoxylin and eosin-stained sections were graded for the
presence of inﬂammatory cells, cellularity and synovial thickness,
as previously described18. Possible grades were 0; normal (synovial
lining <4 cells thick, sparse cellular distribution, with few or no
inﬂammatory cells), 1; mild inﬂammation (synovial lining four or
ﬁve cells thick, increased cellularity with some inﬂammatory cells),
2; moderate inﬂammation (synovial lining six or seven cells thick,
dense cellularity with inﬂammatory cells but not lymphoid
aggregates), 3; severe inﬂammation (synovial lining >7 cells thick,
dense cellularity and inﬂammatory cell inﬁltration, may contain
perivascular lymphoid aggregates).
Immunohistochemistry used monoclonal antibodies to podo-
planin at a dilution of 1:100, or LYVE-1 at a dilution of 1:500, or
CD34 at a dilution of 1:100, each for 60 min, then biotinylated horse
anti-mouse antibodies for 30 min, avidinebiotinealkaline phos-
phatase complex for a further 30 min and developed using
FastRed. All incubations were at room temperature. All sections
from both patient groups were stained within a single staining run
in order to minimise technical variance.
Image analysis
Synovial sections stained for podoplanin were viewed through
a 20 objective lens and the four ﬁelds of view with the highest
lymphatic vascular densities in each section were quantiﬁed using
a KS300 computer-assisted image analysis system (Imaging Asso-
ciates, Bicester, UK). Synovium was delineated interactively, and
podoplanin-positive vessels were deﬁned by interactive thresh-
olding according to hue. Lymphatic vessel proﬁles were identiﬁed
as round or linear podoplanin-positive structures surrounded by
podoplanin-negative tissue. This method is comparable to previous
Table I
Characteristics of the study population
OA PM
Patient numbers 60 37
Female 43% 46%
Median (IQR) age 63 (50e69) 63 (50e69)
Finger nodes (3) 10% 0%
JSN (range 0e6) 5 (IQR 4e5) Not available
OST score (range 0e12) 8 (IQR 8e10) Not available
Total radiographic score (range 0e18) 13 (IQR 12e15) Not available
On medications for diabetes mellitus 2% 3%
The characteristics of each group are shown.
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synovial lymphatics by others5. All histomorphometry was under-
taken by an observer blinded to diagnostic, clinical and radio-
graphic status.
Effusion status
Effusion status in the operated knee for OA cases was deter-
mined as present or absent by one observer (D. Wilson) during
a pre-operative clinical examination, using the balloon sign29.
Radiograph scoring
Pre-operative postero-anterior radiographs for OA cases were
graded by an observer blinded to histological ﬁndings, as an index
of structural disease severity. Joint space narrowing (JSN) and
presence of OST were graded by comparison with a line drawing
atlas, with possible ranges from 0 to 6 and 0 to 12 respectively and
higher scores indicating more severe structural change30. These
individual scores were summed to give a total severity score out of
a possible 18. No radiographs were taken from post mortem
patients.
Data analysis
Lymphatic Vascular Density (LVD) was deﬁned as the number of
podoplanin-positive lymphatic vessel proﬁles per mm2 of syno-
vium in the four ﬁelds of view. LEC fractional area was measured as
the thresholded podoplanin-positive vessel area per mm2 of
synovium in the four ﬁelds of view. Podoplanin-immunoreactive
structures that did not display vascular morphology, when
present, were interactively excluded. Spaces not containing tissue
matrix or cells were excluded from synovium area measurements
to avoid potential confounding by ex vivo and tissue processing
artifacts, in particular the extent of lymphatic dilation.
Data were analysed with Statistical Package for Social Sciences,
version 14 (SPSS Inc, Chicago, IL, USA), using ManneWhitney U-
tests, Spearman’s rank correlation coefﬁcients or c2 statistic.
Further statistical analysis was performed using logistic regression
to attempt to control for possible confounders, and for this analysis
continuous data were divided into quartiles. Age, gender and
histological inﬂammation score, plus any factors found in univar-
iate analyses to be signiﬁcantly associated with the dependent
variable, were deﬁned as potential confounders prior to the study.
P< 0.05 indicated statistical signiﬁcance. Data are presented as
median and interquartile range (IQR).
Materials
Monoclonal antibody anti-podoplanin (cat# 11-003)31 came
from AngioBio, Del Mar, CA, USA. Monoclonal antibodies against
LYVE-1 (clone 537028; cat#MAB20892) or CD3415 (clone QBEnD10;
cat# M7165) came from R&D Systems and Dako respectively. Bio-
tinylated horse anti-mouse immunoglobulin gamma (IgG) antibody
and avidinebiotin complex (ABC) alkaline phosphatase came from
Vector Laboratories Ltd., Peterborough, UK. Except as stated, all
other reagents were from SigmaeAldrich, Poole, UK.
Results
Patient details
Demographics, clinical and radiographic characteristics are
summarised in Table I. The age and gender of both sample groups
were similar due to matching. Radiographic OA severity scoresindicated severe structural change in OA patients, whereas post
mortem cases had been selected to exclude possible subclinical OA.Lymphatic vessel localisation
Podoplanin-positive vessels were found in the deep synovium
in OA and post mortem cases, usually clustered together near blood
vessels [Fig. 1(A)]. Vessels containing erythrocytes were never
positively stained for podoplanin, supporting the speciﬁcity of
podoplanin for lymphatic endothelium. Consecutive tissue sections
demonstrated that podoplanin-positive vessels were CD34-
negative, and CD34-positive blood vessels were podoplanin-
negative [Fig. 1(A, B)]. By contrast, LYVE-1 positive vessels were
often associated with CD34 immunoreactivity, and sometimes
displayed thick walls consistent with staining of blood vessels
[Fig. 1(C, D)]. CD34-positive blood vessels were localised to both
superﬁcial and deep regions of the synovium, and appeared more
abundant than were podoplanin-positive vessels. Podoplanin-
positive vessels were not identiﬁed in subchondral bone, despite
the presence of podoplanin-positive vessels in synovium attached
to osteochondral tissues and despite the replacement of sub-
chondral bone marrow by ﬁbrovascular tissues (data not shown).Lymphatic Vessel Density
Synovia were assessed from 60 knees per group, taken from 60
patients with OA and 37 post mortem cases. In order to reduce
heterogeneity due to factors other than disease group, OA and post-
mortem cases were age-matched, and inclusion of OA cases in the
PM group was minimised by application of rigorous exclusion
criteria.
Synovia from patients with OA displayed lower LVD (median 12
(IQR 0e20) mm2) and lower LEC fractional areas (median 0.6 (IQR
0e1.7)%) than PM samples (median lymphatic vessel density (LVD)
19 (IQR 13e26) mm2, z¼3.4, P¼ 0.001, median LEC fractional
area 2.4 (IQR 1.3e3.8)%, z¼4.5, P< 0.0005, Fig. 2(A, B)).
41% (24/58) OA cases had clinically detectable knee joint effu-
sion (data were missing for two cases). OA synovia from patients
with effusion had lower LVD (median 0 (IQR 0e14) mm2) than OA
cases without (median 15 (IQR 2e22) mm2, z¼ 2.2, P¼ 0.027,
Fig. 2(C)). Difference in LEC fractional area between cases with
and without effusion did not reach statistical signiﬁcance (median
0.0 (IQR 0.0e1.7)% and 1.0 (IQR 0.1e1.7)% respectively, z¼ 1.7,
P¼ 0.081, Fig. 2(D)). No signiﬁcant associations were found
between radiographic severity scores and LVD or LEC fractional area
(see Supplemental Data, Table SI).
Synovial inﬂammation grade was higher in OA (median¼ 3,
IQR: 0e3) compared to PM (median 1 (IQR 0e2) (z¼2.6,
P¼ 0.009) (Fig. 3)). Synovial inﬂammation grades were similar in
cases with or without effusions (median 2 (IQR 0e3) and 3 (IQR
0e3) respectively, z¼ 1.0, P¼ 0.308). Inﬂammation grades were
Fig. 1. Spatial relationships between lymphatic markers and CD34-positive blood vessels in human synovium. A: Podoplanin immunoreactivity (A) is present on a lymphatic vessel
(arrow), but not on an adjacent blood vessel (asterisk). B: CD34 immunoreactivity in a tissue section consecutive to that shown in (A) is demonstrated on blood vessel endothelium,
but not on the adjacent lymphatic vessel. CD34 positive blood vessels were more abundant than podoplanin-positive lymphatic vessel. C: Immunoreactivity for LYVE-1 is
demonstrated on vascular structures (asterisks) that also display CD34-immunoreactivity in a consecutive section (D). Bar¼ 100 mm.
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with LEC fractional area (r¼0.12, P¼ 0.178).
Findings from univariate analyses were supported by logistic
regression analysis. In comparisons between disease groups, LVD
and LEC fractional areas were negatively associated with OA after
adjusting for age, gender and inﬂammation (Table II). Random
selection of one knee for each post-mortem case (giving n¼ 37) did
not alter conclusions from either univariate or logistic regression
analyses (Supplementary data tables SII and SIII respectively). Also,
LVDwas negatively associated with effusion in the patients with OA
after adjusting for age, gender, inﬂammation and radiographic
score (Table III). Synovial inﬂammationwas associated with OA, but
not associated signiﬁcantly with effusion in these analyses.
Discussion
We found that synovial lymphatic density was reduced in
patients with OA undergoing total knee replacement surgery,
compared to non-arthritic controls, and this was associated with
the presence of a clinically detectable effusion, but not with
histological evidence of synovitis.
Lymphatics play key roles in the clearance of tissue ﬂuid and the
trafﬁcking of immune cells in soft tissues. Despite this, study of
lymphatics in human joint tissues has been limited by a paucity
of speciﬁc reagents for their localisation, and limited availability of
joint tissues. In contrast to the current consensus on increased
blood vessel angiogenesis in OA, synovial lymphatics have been
reported to be either absent1 or increased2 in arthritic human
synovia. Our data indicate that podoplanin-positive lymphaticvessels are present in both normal synovium, and in OA synovia. By
studying a large number of non-arthritic knees we have been able
to demonstrate that lymphatic vascular densities are reduced in OA
compared with non-arthritic synovium.
Xu et al have reported numerous lymphatic vessels close to the
intimal lining in inﬂamed human synovia2. We found that
podoplanin-positive lymphatic vessels were localised to deep
regions of both normal and OA synovium, irrespective of the extent
of synovitis, although this does not preclude the possibility that
a subgroup of lymphatic vessels were not detected by our methods.
Another study of normal synovial lymphatics also reported deep
localisation, with vessels close to the synovial lining being exclu-
sively positive for the blood vessel marker PAL-E1. Blood vessels are
much more abundant in human synovium than are lymphatic
vessels, and even a small cross-reaction of reagents between
lymphatic and blood vessels might create a false impression of
increased lymphatic density. Markers such as LYVE-1 and VEGFR3,
although speciﬁc for lymphatics in normal tissues, may be upre-
gulated by blood vessel endothelium during inﬂammation12,17.
LYVE-1 was found in some samples in the current study to label
CD34 positive blood vessels in addition to lymphatics, whereas
podoplanin-positive lymphatics were CD34 negative. These ﬁnd-
ings, together with the thin-walled morphology of podoplanin-
positive vessels, are consistent with podoplanin being a speciﬁc
marker of synovial lymphatic vessels, even in inﬂamed osteoar-
thritic synovium.
Other studies have indicated that podoplanin may also be
expressed by macrophages in some tissues32,33. Podoplanin-
immunoreactive macrophages were not identiﬁed even in
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Fig. 2. Lymphatic densities in knee synovia. Data represent individual synovia and median values for each disease group. Lymphatic densities were lower in OA than in PM controls,
both measured as lymphatic vascular density (A, z¼3.4, P¼ 0.001) and as lymphatic endothelial cell (LEC) fractional area (B, z¼4.5, P< 0.0005). Synovia from patients with OA
displayed lower lymphatic vascular densities in cases in which a joint effusion was present than when absent (C, z¼2.2, P¼ 0.027), although difference in LEC fractional area
between cases with and without effusion did not reach statistical signiﬁcance (D, z¼1.7, P¼ 0.081). PM; post mortem controls, OA; osteoarthritis. Graphs are drawn to different
scales.
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rule out by light microscopy their possible presence closely adja-
cent to lymphatic vessels34.
Our current data support previous ﬁndings by ourselves and
others that synovitis is a feature of OA synovium27,35. Synovitis, as
scored using histology in the current study, is indicative of
increased cellularity. High scores in our OA cases indicate that lowFig. 3. Histological appearances of human knee synovium. Photomicrographs showing repre
median for their respective disease group. A: Non-arthritic post mortem control displaying
characterised by increased cellularity, inﬁltration by inﬂammatory cells, and increased deplymphatic densities are not due to replacement of synovium by
inactive, ﬁbrotic tissue in late stage disease. Increases in blood
vessel density in synovia are associated with histological evidence
of synovitis, an association attributed to the production of angio-
genic factors such as VEGF28,36. Inﬂammation, for example during
wound healing, can also stimulate lymphangiogenesis, through
upregulation of VEGF-C37,38 and previous studies have indicatedsentative samples of OA and non-arthritic synovium displaying synovitis scores that are
grade 1 inﬂammation score. B: OA synovium displaying grade 3 inﬂammation score,
th of lining cell layer. Haematoxylin and eosin stains. Bar¼ 100 mm.
Table II
Logistic regression models of the association between OA and lymphatics
OA vs post mortem LEC fractional area model LVD model
aOR (95% CI) P aOR (95% CI) P
Female Y/N 1.01 (0.43e2.39) 0.983 0.90 (0.39e2.07) 0.795
Age Quartile 0.96 (0.66e1.40) 0.837 1.05 (0.73e1.53) 0.787
Inﬂammation 0e3 1.63 (1.15e2.30) 0.006 1.60 (1.14e2.25) 0.006
Lymphatic endothelial area Quartile 0.51 (0.35e0.75) 0.001 Not included
LVD Quartile Not included 0.59 (0.41e0.86) 0.005
Independent associations with OA (adjusted for other factors in the model) were investigated using two logistic regression analyses; one for each measure of lymphatics in
synovia. In both models, lymphatics showed a negative association with OA as the adjusted odds ratios (aOR) and 95% conﬁdence intervals (CI) were signiﬁcantly less than
unity. Inﬂammation grade was positively associated with OA, and the other measures showed no signiﬁcant relationship in this study.
D.A. Walsh et al. / Osteoarthritis and Cartilage 20 (2012) 405e412410that lymphatic vessel densities may be increased in inﬂamed
synovium2. Despite this, lymphatic vascular densities were not
signiﬁcantly associated with synovitis in our cases, and were
decreased rather than increased in OA synovia. This may suggest
that synovial blood and lymphatic vessel densities are differentially
regulated in OA. Low lymphatic densities may indicate that lym-
phangiogenesis is unable to keep pace with synovial hyperplasia or
oedema, or may be due to damage to the pre-existing lymphatics
during disease. VEGF-C and its receptor VEGFR-3 are expressed in
human synovium12, but do not appear to be sufﬁcient to maintain
lymphatic densities in OA. Although reduced lymphatic vessel
densities in OA synovium were associated with clinical effusion
status, we are unable to determine possible moderating effects of
changes in total synovial lymphatic mass, which depend also on
synovial tissue oedema and hyperplasia.
Joint effusion has been associated with OA radiographic
severity39 and pain40, and has been used as a sign of inﬂammation.
Although synovitis may lead to increased synovial ﬂuid produc-
tion41, the presence of a clinically detectable synovial effusion in
our study was not associated with histological evidence of syno-
vitis, but rather with a reduced density of synovial lymphatics. The
presence of synovial effusion represents an imbalance between the
production and clearance of synovial ﬂuid from the joint cavity.
This leads us to suggest that effusion may be more indicative
of lymphatic dysregulation in patients with OA, rather than of
inﬂammation. This may partly explain the poor predictive value of
clinical effusion for response in OA to intra-articular corticosteroid
injection13.
Our data support the ﬁndings of others42 that subchondral bone
spaces remain devoid of lymphatics even in advanced OA at the
time of joint replacement surgery, and when ﬁbrovascular tissue
has replaced the subchondral bone marrow. Subchondral and
synovial inﬂammationmay each contribute to symptoms in OA15,43,
Differences between these tissue compartments in tissue ﬂuid
drainage and lymphocyte trafﬁcking pathways may point to
differences in the generation and resolution of oedema and
immune responses between these tissue compartments.Table III
Logistic regression models of the association between effusion and lymphatics in OA
Effusion vs no effusion LEC fractional a
aOR (95% CI)
Female Y/N 1.10 (0.32e3.81
Age Quartile 0.66 (0.36e1.23
Radiographic score 0e18 0.96 (0.81e1.12
Inﬂammation 0e3 0.77 (0.48e1.25
Lymphatic endothelial area Quartile 0.56 (0.30e1.06
LVD Quartile Not included
Independent associations with effusion in patients with OA (adjusted for other factors
measure of lymphatics in synovia. LVD showed a negative association with effusion as
showed a signiﬁcant relationship with effusion in this study.Attribution of ﬁndings to the presence of OA can be compro-
mised through confounding by other factors known to be strongly
associated with OA prevalence and severity. In particular,
increasing age and female gender have been associated with knee
OA. We avoided potential confounding ﬁrst by matching between
OA and non-arthritic PM groups, and second by demonstrating that
our ﬁndings were independent of age and gender. This approach
requires selection of cases from a much larger database44. The
Academic Rheumatology tissue repository currently contains knee
samples from >2,000 cases collected at total joint replacement
surgery, and >250 cases collected post mortem. Matching OA cases
against non-arthritic PM cases produced a disease group that was
slightly younger than other local studies that recruited from joint
replacement lists45, and a higher proportion of OA cases weremales
than would be representative of the local community46. Our
method of case selection may have reduced our ability to ﬁnd
signiﬁcant associations between LVD and age or gender. Further
studies with access to a larger group of elderly non-arthritic
patients would be required to conﬁrm whether differences in
lymphatic vessel densities persist with increasing age.
Single time point studies such as ours are subject to several
limitations because we were studying late-stage tissue, and cannot
show temporal associations. Interventional and longitudinal
studies would be required to conﬁrm whether the observed
reduction in lymphatic densities in OA is a consequence of OA, and
whether it contributes to the disease progression. As in previous
studies5, we used a method of ‘hot spot’ quantiﬁcation, which
reduces measurement error attributable to low lymphatic vessel
densities. All histological studies require sampling from the total
synovium and consistent reporting of sampling procedure is
important in interpreting results. We have previously demon-
strated associations between histological synovitis in synovium
from adjacent to the medial tibial plateau and increased synovial
blood vessel growth34 and OA structural pathology27. These asso-
ciations, as well as that with clinical effusion reported here, may
indicate a pathological importance for this synovial region in OA.
Further research would be required to determine whetherrea model LVD model
P aOR (95% CI) P
) 0.886 1.05 (0.29e3.78) 0.945
) 0.189 0.66 (0.35e1.25) 0.199
) 0.579 0.97 (0.83e1.15) 0.750
) 0.291 0.75 (0.45e1.23) 0.249
) 0.077 Not included
0.49 (0.26e0.92) 0.025
in the model) are investigated using two logistic regression analyses; one for each
the aOR and 95% CI were signiﬁcantly less than unity. None of the other measures
D.A. Walsh et al. / Osteoarthritis and Cartilage 20 (2012) 405e412 411lymphatic vessel changes are restricted to this site or representative
of diffuse changes across all synovial compartments. Comparing
results between surgical and post-mortem tissues is another
potential limitation of our study. However, no qualitative differ-
ences in podoplanin staining were observed in the current study
between samples obtained post mortem and those at joint
replacement surgery. Post mortem artefacts would be expected to
reduce podoplanin positive vessel densities, leading us to possibly
underestimate the differences between OA and post mortem
controls. Age and gender were closely matched between disease
groups, which reduced the number of possible confounders,
although other factors related to OA could not be controlled for. For
example, it was not possible in this study to determine whether
effusion status explains differences in lymphatic vessel densities
between OA and post-mortem controls, as clinical effusions were
not assessed in the latter group. Further work is also required to
conﬁrm the relationship between effusion and reduced lymphatic
density in the OA synovium. We assessed effusion by clinical
examination at the time of recruitment. Other measures for quan-
tifying and characterising effusion, for example by ultrasono-
graphic imaging or by biochemical analysis, should be considered
to verify and extend our ﬁndings. Studies of lymphatic vessel
function, including dilation, tissue ﬂuid ﬂow and synovial ﬂuid
composition, could further elucidate how decreased lymphatic
vessel densities may lead to altered effusion status.
In conclusion, we have found a signiﬁcant decrease in LVD in OA
compared to non-arthritic post mortem synovium, and this was
associated with the presence of effusion, but not with synovitis.
These ﬁndings support the hypothesis that reduction in synovial
ﬂuid drainage, due to reduced LVD, may contribute to effusion in
OA. Future studies should conﬁrm this association and explore
pathophysiological mechanisms underlying these processes.
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